You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Cerevance establishes strategic research collaboration with Merck

Cerevance – the clinical-stage drug discovery and development company focused on central nervous system diseases – has announced a multi-year strategic research collaboration with Merck – known as MSD outside the US and Canada – to identify novel targets for Alzheimer’s disease.